Medical Devices & Consumables
Global ADAM23 Polyclonal Antibody Market Research Report 2026
- Mar 17, 26
- ID: 736861
- Pages: 134
- Figures: 135
- Views: 5
This report delivers a comprehensive overview of the global ADAM23 Polyclonal Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding ADAM23 Polyclonal Antibody. The ADAM23 Polyclonal Antibody market size, estimates, and forecasts are provided in terms of sales volume (mg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global ADAM23 Polyclonal Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist ADAM23 Polyclonal Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abcam
Santa
ABGENT
Novus Biologicals
R&D Systems
BioLegend
Thermo Fisher Scientific
BD Biosciences
Merck Millipore
Proteintech
Beijing Biolab Technology
Annolen (Beijing) Biotechnology
Puxi (Shanghai) Biotechnology
Wuhan Biotech
Beijing Biotech
Boersen Biotechnology Shanghai
Shanghai Yuanqi Biotechnology
Merck Life Sciences
Shanghai Bohu Biotechnology
Segment by Type
Rabbit Antibody
Other
by Application
Pharmaceutical Industry
Biomedical research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for ADAM23 Polyclonal Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines ADAM23 Polyclonal Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global ADAM23 Polyclonal Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist ADAM23 Polyclonal Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abcam
Santa
ABGENT
Novus Biologicals
R&D Systems
BioLegend
Thermo Fisher Scientific
BD Biosciences
Merck Millipore
Proteintech
Beijing Biolab Technology
Annolen (Beijing) Biotechnology
Puxi (Shanghai) Biotechnology
Wuhan Biotech
Beijing Biotech
Boersen Biotechnology Shanghai
Shanghai Yuanqi Biotechnology
Merck Life Sciences
Shanghai Bohu Biotechnology
Segment by Type
Rabbit Antibody
Other
by Application
Pharmaceutical Industry
Biomedical research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for ADAM23 Polyclonal Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines ADAM23 Polyclonal Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 ADAM23 Polyclonal Antibody Market Overview
1.1 Product Definition
1.2 ADAM23 Polyclonal Antibody by Type
1.2.1 Global ADAM23 Polyclonal Antibody Market Value by Type: 2025 vs 2032
1.2.2 Rabbit Antibody
1.2.3 Other
1.3 ADAM23 Polyclonal Antibody by Application
1.3.1 Global ADAM23 Polyclonal Antibody Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceutical Industry
1.3.3 Biomedical research
1.3.4 Other
1.4 Global ADAM23 Polyclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global ADAM23 Polyclonal Antibody Revenue 2021–2032
1.4.2 Global ADAM23 Polyclonal Antibody Sales 2021–2032
1.4.3 Global ADAM23 Polyclonal Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 ADAM23 Polyclonal Antibody Market Competition by Manufacturers
2.1 Global ADAM23 Polyclonal Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global ADAM23 Polyclonal Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global ADAM23 Polyclonal Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of ADAM23 Polyclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of ADAM23 Polyclonal Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of ADAM23 Polyclonal Antibody, Product Types and Applications
2.7 Global Key Manufacturers of ADAM23 Polyclonal Antibody, Date of Entry into the Industry
2.8 Global ADAM23 Polyclonal Antibody Market Competitive Situation and Trends
2.8.1 Global ADAM23 Polyclonal Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global ADAM23 Polyclonal Antibody Players Market Share by Revenue
2.8.3 Global ADAM23 Polyclonal Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ADAM23 Polyclonal Antibody Market Scenario by Region
3.1 Global ADAM23 Polyclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global ADAM23 Polyclonal Antibody Sales by Region: 2021–2032
3.2.1 Global ADAM23 Polyclonal Antibody Sales by Region: 2021–2026
3.2.2 Global ADAM23 Polyclonal Antibody Sales by Region: 2027–2032
3.3 Global ADAM23 Polyclonal Antibody Revenue by Region: 2021–2032
3.3.1 Global ADAM23 Polyclonal Antibody Revenue by Region: 2021–2026
3.3.2 Global ADAM23 Polyclonal Antibody Revenue by Region: 2027–2032
3.4 North America ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.4.1 North America ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.4.3 North America ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.5.1 Europe ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.5.3 Europe ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ADAM23 Polyclonal Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific ADAM23 Polyclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific ADAM23 Polyclonal Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.7.3 Latin America ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ADAM23 Polyclonal Antibody Sales by Type (2021–2032)
4.1.1 Global ADAM23 Polyclonal Antibody Sales by Type (2021–2026)
4.1.2 Global ADAM23 Polyclonal Antibody Sales by Type (2027–2032)
4.1.3 Global ADAM23 Polyclonal Antibody Sales Market Share by Type (2021–2032)
4.2 Global ADAM23 Polyclonal Antibody Revenue by Type (2021–2032)
4.2.1 Global ADAM23 Polyclonal Antibody Revenue by Type (2021–2026)
4.2.2 Global ADAM23 Polyclonal Antibody Revenue by Type (2027–2032)
4.2.3 Global ADAM23 Polyclonal Antibody Revenue Market Share by Type (2021–2032)
4.3 Global ADAM23 Polyclonal Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global ADAM23 Polyclonal Antibody Sales by Application (2021–2032)
5.1.1 Global ADAM23 Polyclonal Antibody Sales by Application (2021–2026)
5.1.2 Global ADAM23 Polyclonal Antibody Sales by Application (2027–2032)
5.1.3 Global ADAM23 Polyclonal Antibody Sales Market Share by Application (2021–2032)
5.2 Global ADAM23 Polyclonal Antibody Revenue by Application (2021–2032)
5.2.1 Global ADAM23 Polyclonal Antibody Revenue by Application (2021–2026)
5.2.2 Global ADAM23 Polyclonal Antibody Revenue by Application (2027–2032)
5.2.3 Global ADAM23 Polyclonal Antibody Revenue Market Share by Application (2021–2032)
5.3 Global ADAM23 Polyclonal Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Company Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abcam ADAM23 Polyclonal Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 Santa
6.2.1 Santa Company Information
6.2.2 Santa Description and Business Overview
6.2.3 Santa ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Santa ADAM23 Polyclonal Antibody Product Portfolio
6.2.5 Santa Recent Developments/Updates
6.3 ABGENT
6.3.1 ABGENT Company Information
6.3.2 ABGENT Description and Business Overview
6.3.3 ABGENT ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ABGENT ADAM23 Polyclonal Antibody Product Portfolio
6.3.5 ABGENT Recent Developments/Updates
6.4 Novus Biologicals
6.4.1 Novus Biologicals Company Information
6.4.2 Novus Biologicals Description and Business Overview
6.4.3 Novus Biologicals ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novus Biologicals ADAM23 Polyclonal Antibody Product Portfolio
6.4.5 Novus Biologicals Recent Developments/Updates
6.5 R&D Systems
6.5.1 R&D Systems Company Information
6.5.2 R&D Systems Description and Business Overview
6.5.3 R&D Systems ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 R&D Systems ADAM23 Polyclonal Antibody Product Portfolio
6.5.5 R&D Systems Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Company Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BioLegend ADAM23 Polyclonal Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Thermo Fisher Scientific ADAM23 Polyclonal Antibody Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 BD Biosciences
6.8.1 BD Biosciences Company Information
6.8.2 BD Biosciences Description and Business Overview
6.8.3 BD Biosciences ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BD Biosciences ADAM23 Polyclonal Antibody Product Portfolio
6.8.5 BD Biosciences Recent Developments/Updates
6.9 Merck Millipore
6.9.1 Merck Millipore Company Information
6.9.2 Merck Millipore Description and Business Overview
6.9.3 Merck Millipore ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Merck Millipore ADAM23 Polyclonal Antibody Product Portfolio
6.9.5 Merck Millipore Recent Developments/Updates
6.10 Proteintech
6.10.1 Proteintech Company Information
6.10.2 Proteintech Description and Business Overview
6.10.3 Proteintech ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Proteintech ADAM23 Polyclonal Antibody Product Portfolio
6.10.5 Proteintech Recent Developments/Updates
6.11 Beijing Biolab Technology
6.11.1 Beijing Biolab Technology Company Information
6.11.2 Beijing Biolab Technology Description and Business Overview
6.11.3 Beijing Biolab Technology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Beijing Biolab Technology ADAM23 Polyclonal Antibody Product Portfolio
6.11.5 Beijing Biolab Technology Recent Developments/Updates
6.12 Annolen (Beijing) Biotechnology
6.12.1 Annolen (Beijing) Biotechnology Company Information
6.12.2 Annolen (Beijing) Biotechnology Description and Business Overview
6.12.3 Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.12.5 Annolen (Beijing) Biotechnology Recent Developments/Updates
6.13 Puxi (Shanghai) Biotechnology
6.13.1 Puxi (Shanghai) Biotechnology Company Information
6.13.2 Puxi (Shanghai) Biotechnology Description and Business Overview
6.13.3 Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.13.5 Puxi (Shanghai) Biotechnology Recent Developments/Updates
6.14 Wuhan Biotech
6.14.1 Wuhan Biotech Company Information
6.14.2 Wuhan Biotech Description and Business Overview
6.14.3 Wuhan Biotech ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Wuhan Biotech ADAM23 Polyclonal Antibody Product Portfolio
6.14.5 Wuhan Biotech Recent Developments/Updates
6.15 Beijing Biotech
6.15.1 Beijing Biotech Company Information
6.15.2 Beijing Biotech Description and Business Overview
6.15.3 Beijing Biotech ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beijing Biotech ADAM23 Polyclonal Antibody Product Portfolio
6.15.5 Beijing Biotech Recent Developments/Updates
6.16 Boersen Biotechnology Shanghai
6.16.1 Boersen Biotechnology Shanghai Company Information
6.16.2 Boersen Biotechnology Shanghai Description and Business Overview
6.16.3 Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Product Portfolio
6.16.5 Boersen Biotechnology Shanghai Recent Developments/Updates
6.17 Shanghai Yuanqi Biotechnology
6.17.1 Shanghai Yuanqi Biotechnology Company Information
6.17.2 Shanghai Yuanqi Biotechnology Description and Business Overview
6.17.3 Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.17.5 Shanghai Yuanqi Biotechnology Recent Developments/Updates
6.18 Merck Life Sciences
6.18.1 Merck Life Sciences Company Information
6.18.2 Merck Life Sciences Description and Business Overview
6.18.3 Merck Life Sciences ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Merck Life Sciences ADAM23 Polyclonal Antibody Product Portfolio
6.18.5 Merck Life Sciences Recent Developments/Updates
6.19 Shanghai Bohu Biotechnology
6.19.1 Shanghai Bohu Biotechnology Company Information
6.19.2 Shanghai Bohu Biotechnology Description and Business Overview
6.19.3 Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.19.5 Shanghai Bohu Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ADAM23 Polyclonal Antibody Industry Chain Analysis
7.2 ADAM23 Polyclonal Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ADAM23 Polyclonal Antibody Production Mode & Process Analysis
7.4 ADAM23 Polyclonal Antibody Sales and Marketing
7.4.1 ADAM23 Polyclonal Antibody Sales Channels
7.4.2 ADAM23 Polyclonal Antibody Distributors
7.5 ADAM23 Polyclonal Antibody Customer Analysis
8 ADAM23 Polyclonal Antibody Market Dynamics
8.1 ADAM23 Polyclonal Antibody Industry Trends
8.2 ADAM23 Polyclonal Antibody Market Drivers
8.3 ADAM23 Polyclonal Antibody Market Challenges
8.4 ADAM23 Polyclonal Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 ADAM23 Polyclonal Antibody by Type
1.2.1 Global ADAM23 Polyclonal Antibody Market Value by Type: 2025 vs 2032
1.2.2 Rabbit Antibody
1.2.3 Other
1.3 ADAM23 Polyclonal Antibody by Application
1.3.1 Global ADAM23 Polyclonal Antibody Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceutical Industry
1.3.3 Biomedical research
1.3.4 Other
1.4 Global ADAM23 Polyclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global ADAM23 Polyclonal Antibody Revenue 2021–2032
1.4.2 Global ADAM23 Polyclonal Antibody Sales 2021–2032
1.4.3 Global ADAM23 Polyclonal Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 ADAM23 Polyclonal Antibody Market Competition by Manufacturers
2.1 Global ADAM23 Polyclonal Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global ADAM23 Polyclonal Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global ADAM23 Polyclonal Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of ADAM23 Polyclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of ADAM23 Polyclonal Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of ADAM23 Polyclonal Antibody, Product Types and Applications
2.7 Global Key Manufacturers of ADAM23 Polyclonal Antibody, Date of Entry into the Industry
2.8 Global ADAM23 Polyclonal Antibody Market Competitive Situation and Trends
2.8.1 Global ADAM23 Polyclonal Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global ADAM23 Polyclonal Antibody Players Market Share by Revenue
2.8.3 Global ADAM23 Polyclonal Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ADAM23 Polyclonal Antibody Market Scenario by Region
3.1 Global ADAM23 Polyclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global ADAM23 Polyclonal Antibody Sales by Region: 2021–2032
3.2.1 Global ADAM23 Polyclonal Antibody Sales by Region: 2021–2026
3.2.2 Global ADAM23 Polyclonal Antibody Sales by Region: 2027–2032
3.3 Global ADAM23 Polyclonal Antibody Revenue by Region: 2021–2032
3.3.1 Global ADAM23 Polyclonal Antibody Revenue by Region: 2021–2026
3.3.2 Global ADAM23 Polyclonal Antibody Revenue by Region: 2027–2032
3.4 North America ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.4.1 North America ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.4.3 North America ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.5.1 Europe ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.5.3 Europe ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ADAM23 Polyclonal Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific ADAM23 Polyclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific ADAM23 Polyclonal Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.7.3 Latin America ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa ADAM23 Polyclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa ADAM23 Polyclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa ADAM23 Polyclonal Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ADAM23 Polyclonal Antibody Sales by Type (2021–2032)
4.1.1 Global ADAM23 Polyclonal Antibody Sales by Type (2021–2026)
4.1.2 Global ADAM23 Polyclonal Antibody Sales by Type (2027–2032)
4.1.3 Global ADAM23 Polyclonal Antibody Sales Market Share by Type (2021–2032)
4.2 Global ADAM23 Polyclonal Antibody Revenue by Type (2021–2032)
4.2.1 Global ADAM23 Polyclonal Antibody Revenue by Type (2021–2026)
4.2.2 Global ADAM23 Polyclonal Antibody Revenue by Type (2027–2032)
4.2.3 Global ADAM23 Polyclonal Antibody Revenue Market Share by Type (2021–2032)
4.3 Global ADAM23 Polyclonal Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global ADAM23 Polyclonal Antibody Sales by Application (2021–2032)
5.1.1 Global ADAM23 Polyclonal Antibody Sales by Application (2021–2026)
5.1.2 Global ADAM23 Polyclonal Antibody Sales by Application (2027–2032)
5.1.3 Global ADAM23 Polyclonal Antibody Sales Market Share by Application (2021–2032)
5.2 Global ADAM23 Polyclonal Antibody Revenue by Application (2021–2032)
5.2.1 Global ADAM23 Polyclonal Antibody Revenue by Application (2021–2026)
5.2.2 Global ADAM23 Polyclonal Antibody Revenue by Application (2027–2032)
5.2.3 Global ADAM23 Polyclonal Antibody Revenue Market Share by Application (2021–2032)
5.3 Global ADAM23 Polyclonal Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Company Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abcam ADAM23 Polyclonal Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 Santa
6.2.1 Santa Company Information
6.2.2 Santa Description and Business Overview
6.2.3 Santa ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Santa ADAM23 Polyclonal Antibody Product Portfolio
6.2.5 Santa Recent Developments/Updates
6.3 ABGENT
6.3.1 ABGENT Company Information
6.3.2 ABGENT Description and Business Overview
6.3.3 ABGENT ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ABGENT ADAM23 Polyclonal Antibody Product Portfolio
6.3.5 ABGENT Recent Developments/Updates
6.4 Novus Biologicals
6.4.1 Novus Biologicals Company Information
6.4.2 Novus Biologicals Description and Business Overview
6.4.3 Novus Biologicals ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novus Biologicals ADAM23 Polyclonal Antibody Product Portfolio
6.4.5 Novus Biologicals Recent Developments/Updates
6.5 R&D Systems
6.5.1 R&D Systems Company Information
6.5.2 R&D Systems Description and Business Overview
6.5.3 R&D Systems ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 R&D Systems ADAM23 Polyclonal Antibody Product Portfolio
6.5.5 R&D Systems Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Company Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BioLegend ADAM23 Polyclonal Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Thermo Fisher Scientific ADAM23 Polyclonal Antibody Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 BD Biosciences
6.8.1 BD Biosciences Company Information
6.8.2 BD Biosciences Description and Business Overview
6.8.3 BD Biosciences ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BD Biosciences ADAM23 Polyclonal Antibody Product Portfolio
6.8.5 BD Biosciences Recent Developments/Updates
6.9 Merck Millipore
6.9.1 Merck Millipore Company Information
6.9.2 Merck Millipore Description and Business Overview
6.9.3 Merck Millipore ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Merck Millipore ADAM23 Polyclonal Antibody Product Portfolio
6.9.5 Merck Millipore Recent Developments/Updates
6.10 Proteintech
6.10.1 Proteintech Company Information
6.10.2 Proteintech Description and Business Overview
6.10.3 Proteintech ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Proteintech ADAM23 Polyclonal Antibody Product Portfolio
6.10.5 Proteintech Recent Developments/Updates
6.11 Beijing Biolab Technology
6.11.1 Beijing Biolab Technology Company Information
6.11.2 Beijing Biolab Technology Description and Business Overview
6.11.3 Beijing Biolab Technology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Beijing Biolab Technology ADAM23 Polyclonal Antibody Product Portfolio
6.11.5 Beijing Biolab Technology Recent Developments/Updates
6.12 Annolen (Beijing) Biotechnology
6.12.1 Annolen (Beijing) Biotechnology Company Information
6.12.2 Annolen (Beijing) Biotechnology Description and Business Overview
6.12.3 Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.12.5 Annolen (Beijing) Biotechnology Recent Developments/Updates
6.13 Puxi (Shanghai) Biotechnology
6.13.1 Puxi (Shanghai) Biotechnology Company Information
6.13.2 Puxi (Shanghai) Biotechnology Description and Business Overview
6.13.3 Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.13.5 Puxi (Shanghai) Biotechnology Recent Developments/Updates
6.14 Wuhan Biotech
6.14.1 Wuhan Biotech Company Information
6.14.2 Wuhan Biotech Description and Business Overview
6.14.3 Wuhan Biotech ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Wuhan Biotech ADAM23 Polyclonal Antibody Product Portfolio
6.14.5 Wuhan Biotech Recent Developments/Updates
6.15 Beijing Biotech
6.15.1 Beijing Biotech Company Information
6.15.2 Beijing Biotech Description and Business Overview
6.15.3 Beijing Biotech ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beijing Biotech ADAM23 Polyclonal Antibody Product Portfolio
6.15.5 Beijing Biotech Recent Developments/Updates
6.16 Boersen Biotechnology Shanghai
6.16.1 Boersen Biotechnology Shanghai Company Information
6.16.2 Boersen Biotechnology Shanghai Description and Business Overview
6.16.3 Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Product Portfolio
6.16.5 Boersen Biotechnology Shanghai Recent Developments/Updates
6.17 Shanghai Yuanqi Biotechnology
6.17.1 Shanghai Yuanqi Biotechnology Company Information
6.17.2 Shanghai Yuanqi Biotechnology Description and Business Overview
6.17.3 Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.17.5 Shanghai Yuanqi Biotechnology Recent Developments/Updates
6.18 Merck Life Sciences
6.18.1 Merck Life Sciences Company Information
6.18.2 Merck Life Sciences Description and Business Overview
6.18.3 Merck Life Sciences ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Merck Life Sciences ADAM23 Polyclonal Antibody Product Portfolio
6.18.5 Merck Life Sciences Recent Developments/Updates
6.19 Shanghai Bohu Biotechnology
6.19.1 Shanghai Bohu Biotechnology Company Information
6.19.2 Shanghai Bohu Biotechnology Description and Business Overview
6.19.3 Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Product Portfolio
6.19.5 Shanghai Bohu Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ADAM23 Polyclonal Antibody Industry Chain Analysis
7.2 ADAM23 Polyclonal Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ADAM23 Polyclonal Antibody Production Mode & Process Analysis
7.4 ADAM23 Polyclonal Antibody Sales and Marketing
7.4.1 ADAM23 Polyclonal Antibody Sales Channels
7.4.2 ADAM23 Polyclonal Antibody Distributors
7.5 ADAM23 Polyclonal Antibody Customer Analysis
8 ADAM23 Polyclonal Antibody Market Dynamics
8.1 ADAM23 Polyclonal Antibody Industry Trends
8.2 ADAM23 Polyclonal Antibody Market Drivers
8.3 ADAM23 Polyclonal Antibody Market Challenges
8.4 ADAM23 Polyclonal Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global ADAM23 Polyclonal Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global ADAM23 Polyclonal Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global ADAM23 Polyclonal Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global ADAM23 Polyclonal Antibody Sales (mg) of Key Manufacturers (2021–2026)
Table 5. Global ADAM23 Polyclonal Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global ADAM23 Polyclonal Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market ADAM23 Polyclonal Antibody Average Price (US$/μg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of ADAM23 Polyclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of ADAM23 Polyclonal Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of ADAM23 Polyclonal Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of ADAM23 Polyclonal Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ADAM23 Polyclonal Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on ADAM23 Polyclonal Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ADAM23 Polyclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global ADAM23 Polyclonal Antibody Sales by Region (mg), 2021–2026
Table 18. Global ADAM23 Polyclonal Antibody Sales Market Share by Region (2021–2026)
Table 19. Global ADAM23 Polyclonal Antibody Sales by Region (mg), 2027–2032
Table 20. Global ADAM23 Polyclonal Antibody Sales Market Share by Region (2027–2032)
Table 21. Global ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global ADAM23 Polyclonal Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global ADAM23 Polyclonal Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 27. North America ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 28. North America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 32. Europe ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 33. Europe ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific ADAM23 Polyclonal Antibody Sales by Region (mg), 2021–2026
Table 37. Asia Pacific ADAM23 Polyclonal Antibody Sales by Region (mg), 2027–2032
Table 38. Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 42. Latin America ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 43. Latin America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 47. Middle East and Africa ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 48. Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global ADAM23 Polyclonal Antibody Sales (mg) by Type (2021–2026)
Table 51. Global ADAM23 Polyclonal Antibody Sales (mg) by Type (2027–2032)
Table 52. Global ADAM23 Polyclonal Antibody Sales Market Share by Type (2021–2026)
Table 53. Global ADAM23 Polyclonal Antibody Sales Market Share by Type (2027–2032)
Table 54. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global ADAM23 Polyclonal Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global ADAM23 Polyclonal Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Type (2021–2026)
Table 59. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Type (2027–2032)
Table 60. Global ADAM23 Polyclonal Antibody Sales (mg) by Application (2021–2026)
Table 61. Global ADAM23 Polyclonal Antibody Sales (mg) by Application (2027–2032)
Table 62. Global ADAM23 Polyclonal Antibody Sales Market Share by Application (2021–2026)
Table 63. Global ADAM23 Polyclonal Antibody Sales Market Share by Application (2027–2032)
Table 64. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global ADAM23 Polyclonal Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global ADAM23 Polyclonal Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Application (2021–2026)
Table 69. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Application (2027–2032)
Table 70. Abcam Company Information
Table 71. Abcam Description and Business Overview
Table 72. Abcam ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 73. Abcam ADAM23 Polyclonal Antibody Product
Table 74. Abcam Recent Developments/Updates
Table 75. Santa Company Information
Table 76. Santa Description and Business Overview
Table 77. Santa ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 78. Santa ADAM23 Polyclonal Antibody Product
Table 79. Santa Recent Developments/Updates
Table 80. ABGENT Company Information
Table 81. ABGENT Description and Business Overview
Table 82. ABGENT ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 83. ABGENT ADAM23 Polyclonal Antibody Product
Table 84. ABGENT Recent Developments/Updates
Table 85. Novus Biologicals Company Information
Table 86. Novus Biologicals Description and Business Overview
Table 87. Novus Biologicals ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 88. Novus Biologicals ADAM23 Polyclonal Antibody Product
Table 89. Novus Biologicals Recent Developments/Updates
Table 90. R&D Systems Company Information
Table 91. R&D Systems Description and Business Overview
Table 92. R&D Systems ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 93. R&D Systems ADAM23 Polyclonal Antibody Product
Table 94. R&D Systems Recent Developments/Updates
Table 95. BioLegend Company Information
Table 96. BioLegend Description and Business Overview
Table 97. BioLegend ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 98. BioLegend ADAM23 Polyclonal Antibody Product
Table 99. BioLegend Recent Developments/Updates
Table 100. Thermo Fisher Scientific Company Information
Table 101. Thermo Fisher Scientific Description and Business Overview
Table 102. Thermo Fisher Scientific ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 103. Thermo Fisher Scientific ADAM23 Polyclonal Antibody Product
Table 104. Thermo Fisher Scientific Recent Developments/Updates
Table 105. BD Biosciences Company Information
Table 106. BD Biosciences Description and Business Overview
Table 107. BD Biosciences ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 108. BD Biosciences ADAM23 Polyclonal Antibody Product
Table 109. BD Biosciences Recent Developments/Updates
Table 110. Merck Millipore Company Information
Table 111. Merck Millipore Description and Business Overview
Table 112. Merck Millipore ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 113. Merck Millipore ADAM23 Polyclonal Antibody Product
Table 114. Merck Millipore Recent Developments/Updates
Table 115. Proteintech Company Information
Table 116. Proteintech Description and Business Overview
Table 117. Proteintech ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 118. Proteintech ADAM23 Polyclonal Antibody Product
Table 119. Proteintech Recent Developments/Updates
Table 120. Beijing Biolab Technology Company Information
Table 121. Beijing Biolab Technology Description and Business Overview
Table 122. Beijing Biolab Technology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 123. Beijing Biolab Technology ADAM23 Polyclonal Antibody Product
Table 124. Beijing Biolab Technology Recent Developments/Updates
Table 125. Annolen (Beijing) Biotechnology Company Information
Table 126. Annolen (Beijing) Biotechnology Description and Business Overview
Table 127. Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 128. Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Product
Table 129. Annolen (Beijing) Biotechnology Recent Developments/Updates
Table 130. Puxi (Shanghai) Biotechnology Company Information
Table 131. Puxi (Shanghai) Biotechnology Description and Business Overview
Table 132. Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 133. Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Product
Table 134. Puxi (Shanghai) Biotechnology Recent Developments/Updates
Table 135. Wuhan Biotech Company Information
Table 136. Wuhan Biotech Description and Business Overview
Table 137. Wuhan Biotech ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 138. Wuhan Biotech ADAM23 Polyclonal Antibody Product
Table 139. Wuhan Biotech Recent Developments/Updates
Table 140. Beijing Biotech Company Information
Table 141. Beijing Biotech Description and Business Overview
Table 142. Beijing Biotech ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 143. Beijing Biotech ADAM23 Polyclonal Antibody Product
Table 144. Beijing Biotech Recent Developments/Updates
Table 145. Boersen Biotechnology Shanghai Company Information
Table 146. Boersen Biotechnology Shanghai Description and Business Overview
Table 147. Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 148. Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Product
Table 149. Boersen Biotechnology Shanghai Recent Developments/Updates
Table 150. Shanghai Yuanqi Biotechnology Company Information
Table 151. Shanghai Yuanqi Biotechnology Description and Business Overview
Table 152. Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 153. Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Product
Table 154. Shanghai Yuanqi Biotechnology Recent Developments/Updates
Table 155. Merck Life Sciences Company Information
Table 156. Merck Life Sciences Description and Business Overview
Table 157. Merck Life Sciences ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 158. Merck Life Sciences ADAM23 Polyclonal Antibody Product
Table 159. Merck Life Sciences Recent Developments/Updates
Table 160. Shanghai Bohu Biotechnology Company Information
Table 161. Shanghai Bohu Biotechnology Description and Business Overview
Table 162. Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 163. Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Product
Table 164. Shanghai Bohu Biotechnology Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. ADAM23 Polyclonal Antibody Distributors List
Table 168. ADAM23 Polyclonal Antibody Customers List
Table 169. ADAM23 Polyclonal Antibody Market Trends
Table 170. ADAM23 Polyclonal Antibody Market Drivers
Table 171. ADAM23 Polyclonal Antibody Market Challenges
Table 172. ADAM23 Polyclonal Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of ADAM23 Polyclonal Antibody
Figure 2. Global ADAM23 Polyclonal Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global ADAM23 Polyclonal Antibody Market Share by Type: 2025 & 2032
Figure 4. Rabbit Antibody Product Picture
Figure 5. Other Product Picture
Figure 6. Global ADAM23 Polyclonal Antibody Market Value by Application (US$ Million), 2021–2032
Figure 7. Global ADAM23 Polyclonal Antibody Market Share by Application: 2025 & 2032
Figure 8. Pharmaceutical Industry
Figure 9. Biomedical research
Figure 10. Other
Figure 11. Global ADAM23 Polyclonal Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global ADAM23 Polyclonal Antibody Market Size (US$ Million), 2021–2032
Figure 13. Global ADAM23 Polyclonal Antibody Sales (mg), 2021–2032
Figure 14. Global ADAM23 Polyclonal Antibody Average Price (US$/μg), 2021–2032
Figure 15. ADAM23 Polyclonal Antibody Report Years Considered
Figure 16. ADAM23 Polyclonal Antibody Sales Share by Manufacturers in 2025
Figure 17. Global ADAM23 Polyclonal Antibody Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global ADAM23 Polyclonal Antibody Players: Market Share by Revenue in ADAM23 Polyclonal Antibody in 2025
Figure 19. ADAM23 Polyclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global ADAM23 Polyclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 22. North America ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 23. United States ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 26. Europe ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 27. Germany ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific ADAM23 Polyclonal Antibody Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific ADAM23 Polyclonal Antibody Revenue Market Share by Region (2021–2032)
Figure 34. China ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 42. Latin America ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 43. Mexico ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 49. Turkey ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of ADAM23 Polyclonal Antibody by Type (2021–2032)
Figure 53. Global Revenue Market Share of ADAM23 Polyclonal Antibody by Type (2021–2032)
Figure 54. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Type (2021–2032)
Figure 55. Global Sales Market Share of ADAM23 Polyclonal Antibody by Application (2021–2032)
Figure 56. Global Revenue Market Share of ADAM23 Polyclonal Antibody by Application (2021–2032)
Figure 57. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Application (2021–2032)
Figure 58. ADAM23 Polyclonal Antibody Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global ADAM23 Polyclonal Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global ADAM23 Polyclonal Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global ADAM23 Polyclonal Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global ADAM23 Polyclonal Antibody Sales (mg) of Key Manufacturers (2021–2026)
Table 5. Global ADAM23 Polyclonal Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global ADAM23 Polyclonal Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market ADAM23 Polyclonal Antibody Average Price (US$/μg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of ADAM23 Polyclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of ADAM23 Polyclonal Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of ADAM23 Polyclonal Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of ADAM23 Polyclonal Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ADAM23 Polyclonal Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on ADAM23 Polyclonal Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ADAM23 Polyclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global ADAM23 Polyclonal Antibody Sales by Region (mg), 2021–2026
Table 18. Global ADAM23 Polyclonal Antibody Sales Market Share by Region (2021–2026)
Table 19. Global ADAM23 Polyclonal Antibody Sales by Region (mg), 2027–2032
Table 20. Global ADAM23 Polyclonal Antibody Sales Market Share by Region (2027–2032)
Table 21. Global ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global ADAM23 Polyclonal Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global ADAM23 Polyclonal Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 27. North America ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 28. North America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 32. Europe ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 33. Europe ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific ADAM23 Polyclonal Antibody Sales by Region (mg), 2021–2026
Table 37. Asia Pacific ADAM23 Polyclonal Antibody Sales by Region (mg), 2027–2032
Table 38. Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific ADAM23 Polyclonal Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 42. Latin America ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 43. Latin America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa ADAM23 Polyclonal Antibody Sales by Country (mg), 2021–2026
Table 47. Middle East and Africa ADAM23 Polyclonal Antibody Sales by Country (mg), 2027–2032
Table 48. Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa ADAM23 Polyclonal Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global ADAM23 Polyclonal Antibody Sales (mg) by Type (2021–2026)
Table 51. Global ADAM23 Polyclonal Antibody Sales (mg) by Type (2027–2032)
Table 52. Global ADAM23 Polyclonal Antibody Sales Market Share by Type (2021–2026)
Table 53. Global ADAM23 Polyclonal Antibody Sales Market Share by Type (2027–2032)
Table 54. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global ADAM23 Polyclonal Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global ADAM23 Polyclonal Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Type (2021–2026)
Table 59. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Type (2027–2032)
Table 60. Global ADAM23 Polyclonal Antibody Sales (mg) by Application (2021–2026)
Table 61. Global ADAM23 Polyclonal Antibody Sales (mg) by Application (2027–2032)
Table 62. Global ADAM23 Polyclonal Antibody Sales Market Share by Application (2021–2026)
Table 63. Global ADAM23 Polyclonal Antibody Sales Market Share by Application (2027–2032)
Table 64. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global ADAM23 Polyclonal Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global ADAM23 Polyclonal Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global ADAM23 Polyclonal Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Application (2021–2026)
Table 69. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Application (2027–2032)
Table 70. Abcam Company Information
Table 71. Abcam Description and Business Overview
Table 72. Abcam ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 73. Abcam ADAM23 Polyclonal Antibody Product
Table 74. Abcam Recent Developments/Updates
Table 75. Santa Company Information
Table 76. Santa Description and Business Overview
Table 77. Santa ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 78. Santa ADAM23 Polyclonal Antibody Product
Table 79. Santa Recent Developments/Updates
Table 80. ABGENT Company Information
Table 81. ABGENT Description and Business Overview
Table 82. ABGENT ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 83. ABGENT ADAM23 Polyclonal Antibody Product
Table 84. ABGENT Recent Developments/Updates
Table 85. Novus Biologicals Company Information
Table 86. Novus Biologicals Description and Business Overview
Table 87. Novus Biologicals ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 88. Novus Biologicals ADAM23 Polyclonal Antibody Product
Table 89. Novus Biologicals Recent Developments/Updates
Table 90. R&D Systems Company Information
Table 91. R&D Systems Description and Business Overview
Table 92. R&D Systems ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 93. R&D Systems ADAM23 Polyclonal Antibody Product
Table 94. R&D Systems Recent Developments/Updates
Table 95. BioLegend Company Information
Table 96. BioLegend Description and Business Overview
Table 97. BioLegend ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 98. BioLegend ADAM23 Polyclonal Antibody Product
Table 99. BioLegend Recent Developments/Updates
Table 100. Thermo Fisher Scientific Company Information
Table 101. Thermo Fisher Scientific Description and Business Overview
Table 102. Thermo Fisher Scientific ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 103. Thermo Fisher Scientific ADAM23 Polyclonal Antibody Product
Table 104. Thermo Fisher Scientific Recent Developments/Updates
Table 105. BD Biosciences Company Information
Table 106. BD Biosciences Description and Business Overview
Table 107. BD Biosciences ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 108. BD Biosciences ADAM23 Polyclonal Antibody Product
Table 109. BD Biosciences Recent Developments/Updates
Table 110. Merck Millipore Company Information
Table 111. Merck Millipore Description and Business Overview
Table 112. Merck Millipore ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 113. Merck Millipore ADAM23 Polyclonal Antibody Product
Table 114. Merck Millipore Recent Developments/Updates
Table 115. Proteintech Company Information
Table 116. Proteintech Description and Business Overview
Table 117. Proteintech ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 118. Proteintech ADAM23 Polyclonal Antibody Product
Table 119. Proteintech Recent Developments/Updates
Table 120. Beijing Biolab Technology Company Information
Table 121. Beijing Biolab Technology Description and Business Overview
Table 122. Beijing Biolab Technology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 123. Beijing Biolab Technology ADAM23 Polyclonal Antibody Product
Table 124. Beijing Biolab Technology Recent Developments/Updates
Table 125. Annolen (Beijing) Biotechnology Company Information
Table 126. Annolen (Beijing) Biotechnology Description and Business Overview
Table 127. Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 128. Annolen (Beijing) Biotechnology ADAM23 Polyclonal Antibody Product
Table 129. Annolen (Beijing) Biotechnology Recent Developments/Updates
Table 130. Puxi (Shanghai) Biotechnology Company Information
Table 131. Puxi (Shanghai) Biotechnology Description and Business Overview
Table 132. Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 133. Puxi (Shanghai) Biotechnology ADAM23 Polyclonal Antibody Product
Table 134. Puxi (Shanghai) Biotechnology Recent Developments/Updates
Table 135. Wuhan Biotech Company Information
Table 136. Wuhan Biotech Description and Business Overview
Table 137. Wuhan Biotech ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 138. Wuhan Biotech ADAM23 Polyclonal Antibody Product
Table 139. Wuhan Biotech Recent Developments/Updates
Table 140. Beijing Biotech Company Information
Table 141. Beijing Biotech Description and Business Overview
Table 142. Beijing Biotech ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 143. Beijing Biotech ADAM23 Polyclonal Antibody Product
Table 144. Beijing Biotech Recent Developments/Updates
Table 145. Boersen Biotechnology Shanghai Company Information
Table 146. Boersen Biotechnology Shanghai Description and Business Overview
Table 147. Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 148. Boersen Biotechnology Shanghai ADAM23 Polyclonal Antibody Product
Table 149. Boersen Biotechnology Shanghai Recent Developments/Updates
Table 150. Shanghai Yuanqi Biotechnology Company Information
Table 151. Shanghai Yuanqi Biotechnology Description and Business Overview
Table 152. Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 153. Shanghai Yuanqi Biotechnology ADAM23 Polyclonal Antibody Product
Table 154. Shanghai Yuanqi Biotechnology Recent Developments/Updates
Table 155. Merck Life Sciences Company Information
Table 156. Merck Life Sciences Description and Business Overview
Table 157. Merck Life Sciences ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 158. Merck Life Sciences ADAM23 Polyclonal Antibody Product
Table 159. Merck Life Sciences Recent Developments/Updates
Table 160. Shanghai Bohu Biotechnology Company Information
Table 161. Shanghai Bohu Biotechnology Description and Business Overview
Table 162. Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Sales (mg), Revenue (US$ Million), Price (US$/μg), and Gross Margin (2021–2026)
Table 163. Shanghai Bohu Biotechnology ADAM23 Polyclonal Antibody Product
Table 164. Shanghai Bohu Biotechnology Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. ADAM23 Polyclonal Antibody Distributors List
Table 168. ADAM23 Polyclonal Antibody Customers List
Table 169. ADAM23 Polyclonal Antibody Market Trends
Table 170. ADAM23 Polyclonal Antibody Market Drivers
Table 171. ADAM23 Polyclonal Antibody Market Challenges
Table 172. ADAM23 Polyclonal Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of ADAM23 Polyclonal Antibody
Figure 2. Global ADAM23 Polyclonal Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global ADAM23 Polyclonal Antibody Market Share by Type: 2025 & 2032
Figure 4. Rabbit Antibody Product Picture
Figure 5. Other Product Picture
Figure 6. Global ADAM23 Polyclonal Antibody Market Value by Application (US$ Million), 2021–2032
Figure 7. Global ADAM23 Polyclonal Antibody Market Share by Application: 2025 & 2032
Figure 8. Pharmaceutical Industry
Figure 9. Biomedical research
Figure 10. Other
Figure 11. Global ADAM23 Polyclonal Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global ADAM23 Polyclonal Antibody Market Size (US$ Million), 2021–2032
Figure 13. Global ADAM23 Polyclonal Antibody Sales (mg), 2021–2032
Figure 14. Global ADAM23 Polyclonal Antibody Average Price (US$/μg), 2021–2032
Figure 15. ADAM23 Polyclonal Antibody Report Years Considered
Figure 16. ADAM23 Polyclonal Antibody Sales Share by Manufacturers in 2025
Figure 17. Global ADAM23 Polyclonal Antibody Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global ADAM23 Polyclonal Antibody Players: Market Share by Revenue in ADAM23 Polyclonal Antibody in 2025
Figure 19. ADAM23 Polyclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global ADAM23 Polyclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 22. North America ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 23. United States ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 26. Europe ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 27. Germany ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific ADAM23 Polyclonal Antibody Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific ADAM23 Polyclonal Antibody Revenue Market Share by Region (2021–2032)
Figure 34. China ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 42. Latin America ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 43. Mexico ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa ADAM23 Polyclonal Antibody Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa ADAM23 Polyclonal Antibody Revenue Market Share by Country (2021–2032)
Figure 49. Turkey ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE ADAM23 Polyclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of ADAM23 Polyclonal Antibody by Type (2021–2032)
Figure 53. Global Revenue Market Share of ADAM23 Polyclonal Antibody by Type (2021–2032)
Figure 54. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Type (2021–2032)
Figure 55. Global Sales Market Share of ADAM23 Polyclonal Antibody by Application (2021–2032)
Figure 56. Global Revenue Market Share of ADAM23 Polyclonal Antibody by Application (2021–2032)
Figure 57. Global ADAM23 Polyclonal Antibody Price (US$/μg) by Application (2021–2032)
Figure 58. ADAM23 Polyclonal Antibody Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232